These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 1586373

  • 1. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M, Passoni A, Casciarri I, Bosetti P, Piazzoni L, Cazzulani P, Gandolfi CA, Tofanetti O, Ceserani R.
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D, Collodel A, Semeraro C, Gaviraghi G, Carpi C.
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats.
    Nomura M, Kimura Y, Yoshida M, Satoh S.
    Arzneimittelforschung; 1989 Dec; 39(12):1542-5. PubMed ID: 2624602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive effects of a new dihydropyridine calcium antagonist.
    Kimura Y, Fukui H, Tanaka M, Okamoto M, Morino A, Miura A, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D, Roy F, Brown NL.
    Therapie; 1989 Sep; 44(3):203-8. PubMed ID: 2781506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.